Navigation Links
Hopkins Children's study: Folic acid may help treat allergies, asthma
Date:4/29/2009

Folic acid, or vitamin B9, essential for red blood cell health and long known to reduce the risk of spinal birth defects, may also suppress allergic reactions and lessen the severity of allergy and asthma symptoms, according to new research from the Johns Hopkins Children's Center.

In what is believed to be the first study in humans examining the link between blood levels of folate the naturally occurring form of folic acid and allergies, the Hopkins scientists say results add to mounting evidence that folate can help regulate inflammation. Recent studies, including research from Hopkins, have found a link between folate levels and inflammation-mediated diseases, including heart disease. A report on the Hopkins Children's findings appears online ahead of print in the Journal of Allergy & Clinical Immunology.

Cautioning that it's far too soon to recommend folic acid supplements to prevent or treat people with asthma and allergies, the researchers emphasize that more research needs to be done to confirm their results, and to establish safe doses and risks.

Reviewing the medical records of more than 8,000 people ages 2 to 85 the investigators tracked the effect of folate levels on respiratory and allergic symptoms and on levels of IgE antibodies, immune system markers that rise in response to an allergen. People with higher blood levels of folate had fewer IgE antibodies, fewer reported allergies, less wheezing and lower likelihood of asthma, researchers report.

"Our findings are a clear indication that folic acid may indeed help regulate immune response to allergens, and may reduce allergy and asthma symptoms," says lead investigator Elizabeth Matsui, M.D. M.H.S., pediatric allergist at Hopkins Children's. "But we still need to figure out the exact mechanism behind it, and to do so we need studies that follow people receiving treatment with folic acid, before we even consider supplementation with folic acid to treat
'/>"/>

Contact: Ekaterina Pesheva
epeshev1@jhmi.edu
410-516-4996
Johns Hopkins Medical Institutions
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Ex-White House Drug Czar McCaffrey, U.S. Congress Drug Caucus Chair Cummings, CRC Health CEO Karlin Join Hopkins Researchers at News Conference April 17 on Breakthrough Study: Internet Video Drug Treatment as Effective as Traditional Counseling
2. Three Johns Hopkins researchers named Howard Hughes Medical Institute early career scientists
3. Johns Hopkins safety team works to eliminate bloodstream infections in the nation and the world
4. MedVance Institute Promotes John L. Hopkins to Chairman of the Board of Directors
5. Johns Hopkins leads first 12-patient, multicenter domino donor kidney transplant
6. New Johns Hopkins imaging center to widen windows on the brain
7. Johns Hopkins researchers discover new schizophrenia gene
8. Hopkins transplant surgeons remove healthy kidney through donors vagina
9. MEMOTEXT Collaborating with Johns Hopkins University To Evaluate Technology-Driven Adherence Programs
10. Hopkins-led team solves failed vaccine mystery
11. Posit Science Invited to Speak at Johns Hopkins University About Cutting Edge Cognitive Training Interventions
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:So Many Nursing Scrubs, So Many Decisions: blue sky scrubs Offers Tips on How to Find That Perfect Set of Medical Scrubs 2Health News:So Many Nursing Scrubs, So Many Decisions: blue sky scrubs Offers Tips on How to Find That Perfect Set of Medical Scrubs 3Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 2Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 3Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 4Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 5Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 6Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 7Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 8Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 9Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 10Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 11Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 12Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 13Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 14Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 15Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 16Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 17Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 18Health News:Boys and Girls Clubs of Central Oregon Get $10K Regence Grant 2Health News:2008 AAAS Newcomb Cleveland Prize recognizes science paper on limb regeneration in newts 2Health News:Long and Lovely Lashes by LATISSE(TM) Now Available Through Plastic Surgery Services of Fredericksburg 2Health News:Tuba Spells Trouble for Young Musician 2
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3AMERIGROUP Corporation Names Two New Executives 58138 1AMERIGROUP Corporation Names Two New Executives 58138 2AMERIGROUP Corporation Names Two New Executives 58138 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 1Bubble Trouble Team Hits the Lab for Good Hygiene 58133 2Bubble Trouble Team Hits the Lab for Good Hygiene 58133 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 4Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 1Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 2Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 3
Other Medicine Technology:New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 2Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 3Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 4Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 6Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 7